JP2019500860A5 - - Google Patents

Download PDF

Info

Publication number
JP2019500860A5
JP2019500860A5 JP2018526926A JP2018526926A JP2019500860A5 JP 2019500860 A5 JP2019500860 A5 JP 2019500860A5 JP 2018526926 A JP2018526926 A JP 2018526926A JP 2018526926 A JP2018526926 A JP 2018526926A JP 2019500860 A5 JP2019500860 A5 JP 2019500860A5
Authority
JP
Japan
Prior art keywords
virus
cells
cell
derived
nuclease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018526926A
Other languages
English (en)
Japanese (ja)
Other versions
JP7189017B2 (ja
JP2019500860A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2016/051147 external-priority patent/WO2017088018A1/en
Publication of JP2019500860A publication Critical patent/JP2019500860A/ja
Publication of JP2019500860A5 publication Critical patent/JP2019500860A5/ja
Priority to JP2022193050A priority Critical patent/JP2023014322A/ja
Application granted granted Critical
Publication of JP7189017B2 publication Critical patent/JP7189017B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018526926A 2015-11-24 2016-11-23 細胞培養におけるウイルスの生産 Active JP7189017B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022193050A JP2023014322A (ja) 2015-11-24 2022-12-01 細胞培養におけるウイルスの生産

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2015904851 2015-11-24
AU2015904851A AU2015904851A0 (en) 2015-11-24 Production of viruses in cell culture
PCT/AU2016/051147 WO2017088018A1 (en) 2015-11-24 2016-11-23 Production of viruses in cell culture

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022193050A Division JP2023014322A (ja) 2015-11-24 2022-12-01 細胞培養におけるウイルスの生産

Publications (3)

Publication Number Publication Date
JP2019500860A JP2019500860A (ja) 2019-01-17
JP2019500860A5 true JP2019500860A5 (enExample) 2020-01-09
JP7189017B2 JP7189017B2 (ja) 2022-12-13

Family

ID=58762866

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018526926A Active JP7189017B2 (ja) 2015-11-24 2016-11-23 細胞培養におけるウイルスの生産
JP2022193050A Pending JP2023014322A (ja) 2015-11-24 2022-12-01 細胞培養におけるウイルスの生産

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022193050A Pending JP2023014322A (ja) 2015-11-24 2022-12-01 細胞培養におけるウイルスの生産

Country Status (10)

Country Link
US (4) US11174466B2 (enExample)
EP (1) EP3380611A4 (enExample)
JP (2) JP7189017B2 (enExample)
KR (1) KR20180081615A (enExample)
CN (1) CN108603188A (enExample)
AU (2) AU2016361455A1 (enExample)
BR (1) BR112018010499A8 (enExample)
CA (2) CA3247290A1 (enExample)
MX (2) MX387420B (enExample)
WO (1) WO2017088018A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3380616A4 (en) 2015-11-24 2019-11-06 Commonwealth Scientific and Industrial Research Organisation MANUFACTURE OF VIRUSES IN BIRDS
CN108603188A (zh) 2015-11-24 2018-09-28 联邦科学技术研究组织 在细胞培养物中产生病毒
MX2021008797A (es) 2019-01-23 2022-01-31 Regeneron Pharma Tratamiento de afecciones oftalmicas con inhibidores de proteinas relacionadas a angiopoyetina 7 (angptl7).
US11845989B2 (en) 2019-01-23 2023-12-19 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
CN110129281A (zh) * 2019-05-15 2019-08-16 成都天邦生物制品有限公司 一种使用悬浮细胞培养新城疫病毒的方法及应用
KR20230148819A (ko) 2021-02-26 2023-10-25 리제너론 파마슈티칼스 인코포레이티드 글루코코르티코이드 및 안지오포이에틴-유사 7 (angptl7) 억제제를 이용한 염증의 치료
KR102898506B1 (ko) * 2021-04-30 2025-12-10 서울대학교산학협력단 바이러스 백신 생산용 조류 세포 제조용 조성물 및 바이러스 저항성 조류 세포 제조용 조성물
CN114774418B (zh) * 2022-04-19 2023-11-14 深圳市人民医院 shRNA分子及其在敲低TM9SF2基因表达中的应用
CN116656628A (zh) * 2023-07-31 2023-08-29 深圳市卫光生物制品股份有限公司 一种痘病毒载体疫苗的制备方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162215A (en) 1988-09-22 1992-11-10 Amgen Inc. Method of gene transfer into chickens and other avian species
DK2316923T3 (en) * 1998-06-12 2018-01-08 Icahn School Med Mount Sinai Attenuated influenza viruses with altered interferon antagonist activity for use as vaccines and drugs
EP1098961B1 (en) * 1998-06-12 2008-01-16 Mount Sinai School Of Medicine Of The City University Of New York Interferon inducing genetically engineered attenuated viruses
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US20030104526A1 (en) 1999-03-24 2003-06-05 Qiang Liu Position dependent recognition of GNN nucleotide triplets by zinc fingers
US8202979B2 (en) 2002-02-20 2012-06-19 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
EP1341914A2 (en) 2000-12-07 2003-09-10 Sangamo Biosciences Inc. Regulation of angiogenesis with zinc finger proteins
DK1353941T3 (da) 2001-01-22 2013-06-17 Sangamo Biosciences Inc Modificerede zinkfingerbindingsproteiner
AU2002225187A1 (en) 2001-01-22 2002-07-30 Sangamo Biosciences, Inc. Zinc finger polypeptides and their use
US7145057B2 (en) 2002-02-01 2006-12-05 Origen Therapeutics, Inc. Chimeric bird from embryonic stem cells
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
CA2595576A1 (en) 2005-02-01 2006-08-10 Origen Therapeutics, Inc. Transgenic chickens
EP2251034B1 (en) 2005-12-02 2018-02-14 Icahn School of Medicine at Mount Sinai Chimeric newcastle disease viruses presenting non-native surface proteins and uses thereof
US9187758B2 (en) 2006-12-14 2015-11-17 Sangamo Biosciences, Inc. Optimized non-canonical zinc finger proteins
RU2562108C2 (ru) 2007-09-20 2015-09-10 Коммонвелт Сайентифик Энд Индастриал Рисерч Органайзейшн Новые цитокины птиц и кодирующие их генетические последовательности
AU2010226313B2 (en) 2009-03-20 2014-10-09 Sangamo Therapeutics, Inc. Modification of CXCR4 using engineered zinc finger proteins
WO2011005765A1 (en) 2009-07-06 2011-01-13 Alnylam Pharmaceuticals, Inc. Bioprocessing
US20120178647A1 (en) 2009-08-03 2012-07-12 The General Hospital Corporation Engineering of zinc finger arrays by context-dependent assembly
EP2295543A1 (en) 2009-09-11 2011-03-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for the preparation of an influenza virus
EP2510087A2 (en) * 2009-12-11 2012-10-17 The Brigham and Women's Hospital, Inc. Pathogen restriction factors
WO2012164130A1 (es) 2011-05-27 2012-12-06 Consejo Superior De Investigaciones Científicas (Csic) Construcción de células deficitarias en un modulador negativo del virus de la gripe para incrementar la producción de virus vacunales
WO2013059299A1 (en) * 2011-10-17 2013-04-25 The Uab Research Foundation Antibodies for interferon subtypes and interferon/interferon receptor ternary complex and uses thereof
AU2013204327B2 (en) 2012-04-20 2016-09-01 Aviagen Cell transfection method
WO2013166264A2 (en) 2012-05-02 2013-11-07 University Of Georgia Research Foundation, Inc. Methods for altering virus replication
WO2014078502A1 (en) * 2012-11-16 2014-05-22 Novartis Ag Use of il-1 beta binding antibodies for treating peripheral arterial disease
RU2015137703A (ru) 2013-02-05 2017-03-09 Юниверсити Оф Джорджиа Рисерч Фаундейшн, Инк. Линии клеток для получения вирусов и способы их применения
CN105121634B (zh) 2013-03-13 2019-07-26 易木农麦克斯有限公司 具有提高的病毒生产能力的细胞系及其生产方法
US9902973B2 (en) 2013-04-11 2018-02-27 Caribou Biosciences, Inc. Methods of modifying a target nucleic acid with an argonaute
GB201310031D0 (en) 2013-06-05 2013-07-17 Pirbright Inst The Cell
GB201310432D0 (en) 2013-06-12 2013-07-24 Univ St Andrews Virus Production
CN104560864B (zh) * 2014-12-22 2017-08-11 中国科学院微生物研究所 利用CRISPR‑Cas9系统构建的敲除IFN‑β基因的293T细胞系
CN104694576B (zh) 2015-03-30 2018-04-17 山东省农业科学院家禽研究所 一种沉默df‑1细胞系中ifnar1基因的方法
EP3380616A4 (en) 2015-11-24 2019-11-06 Commonwealth Scientific and Industrial Research Organisation MANUFACTURE OF VIRUSES IN BIRDS
CN108603188A (zh) 2015-11-24 2018-09-28 联邦科学技术研究组织 在细胞培养物中产生病毒

Similar Documents

Publication Publication Date Title
JP2019500860A5 (enExample)
CA2805505C (en) Chimeric influenza viruses having reduced ability to reassort with other influenza viruses and uses thereof
US11510974B2 (en) Mutant virus, preparation method therefor and application thereof
CA2646526C (en) Methods and compositions for expressing negative-sense viral rna in canine cells
US20140227310A1 (en) Recombinant influenza virus highly expressing ha protein and preparation method and use thereof
US20170321192A1 (en) Recombinant RNA Viruses and Uses Thereof
JP7189017B2 (ja) 細胞培養におけるウイルスの生産
WO2021004389A1 (zh) 蛋白水解靶向病毒、其活疫苗及其制备方法和用途
WO2016134678A1 (zh) 新的甲型流感病毒哺乳动物细胞适应株及其制备和应用
EP3650536B1 (en) Method for preparing influenza working virus seed stock, method for preparing influenza vaccine using same seed stock, and virus seed stock prepared by same method
CN103118704B (zh) 经修饰的病毒株及用于改善流感病毒的疫苗种子的产生的方法
JP6335167B2 (ja) 感染性インフルエンザウイルスの産生
Guo et al. Comprehensive analysis of the key amino acid substitutions in the polymerase and NP of avian influenza virus that enhance polymerase activity and affect adaptation to mammalian hosts
CN105132459A (zh) 人类ptx3重组蛋白的制备方法及应用
TWI640628B (zh) 促進流感病毒複製之ｈＳｌｕ７基因轉殖細胞
Liang et al. Research of Recombinant Influenza A Virus as a Vector for Mycoplasma Pneumoniae P1a and P30a
Markushin et al. Creation of live influenza vaccines with the use of site-specific mutagenesis
McMillen Development of Inducible Anti-influenza Therapies
Lee ChungYoung et al. Effect of the fourth nucleotide at the 3′ end of neuraminidase and matrix viral genomic RNA on the pathogenicity of influenza virus A/PR/8/34.
Xia Delivery of immunomodulatory miRNAs using genetically modified influenza viruses